Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
acetaminophen (tylenol) (4 trials)
sebacoyl dinalbuphine ester (Naldebain) (1 trial)
tynadote (1 trial)
mannitol (Osmitrol) (1 trial)
snp-630 (1 trial)
sucralose (1 trial)
snp-612 (1 trial)
Fatty Liver (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 2)
Trials (8 total)
Trial APIs (7 total)